Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 33 Breast Neoplasms 26 Triple Negative Breast Neoplasms 17 Prostatic Neoplasms 16 Fallopian Tube Neoplasms 11 Neoplasms 9 Fanconi Anemia, Complementation Group D1 7 Endometrial Neoplasms 7 Pancreatic Neoplasms 6 Glioma 6 Carcinoma, Ovarian Epithelial 6 Stomach Neoplasms 5 Small Cell Lung Carcinoma 5 Sarcoma 5 Neoplasm Metastasis 5 Cholangiocarcinoma 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Lymphoma, Non-Hodgkin 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Breast Cancer 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Osteosarcoma 3 Lung Neoplasms 3 Glioblastoma 3 Colorectal Neoplasms 3 Carcinosarcoma 3 Carcinoma, Renal Cell 3 Wilms Tumor 2

Interventions

aldesleukin 22 Sunitinib 21 Bevacizumab 16 Interleukin-2 14 Everolimus 14 Interferon-alpha 13 Gemcitabine 13 Cyclophosphamide 13 fludarabine phosphate 11 Peripheral Blood Stem Cell Transplantation 9 Sorafenib 8 Filgrastim 8 Axitinib 8 Nivolumab 7 pembrolizumab 6 Ipilimumab 6 Doxorubicin 6 Carboplatin 6 sargramostim 5 cabozantinib 5 Capecitabine 5 Thalidomide 4 Tacrolimus 4 Radiotherapy 4 Radiosurgery 4 Neoadjuvant Therapy 4 Mycophenolic Acid 4 Magnetic Resonance Spectroscopy 4 Erlotinib Hydrochloride 4 Chemotherapy, Adjuvant 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Kidney Neoplasms × olaparib × Clear all

NCT03786796 2026-03-30

ORCHID

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡